Byeong Keon Son, president of Wuestec, is taking over the post of CEO. The expansion of duties, described by the company as a major corporate repositioning, puts Son in charge of Wuestec's strategic direction, product development, distribution, and
Byeong Keon Son, president of Wuestec, is taking over the post of CEO. The expansion of duties, described by the company as a major corporate repositioning, puts Son in charge of Wuestec's strategic direction, product development, distribution, and financial performance. Son joined Wuestec as president in 2000. Before then, he was in charge of strategic development at Gemini Consulting in New York.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.